REACH analysis shows benefits outweigh costs

Helsinki – An analysis by the European Chemicals Agency (ECHA) has found that the benefits of authorising hazardous chemicals under the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) regulation outweigh costs by 15 to one.

The report, ‘Socio-economic impacts of REACH authorisations’, calculates that €281 million of health risks arise each year from the continued use of chemicals that require authorisation, but that costs would be around €4.2 billion if the REACH system were not in place.

ECHA’s report was intended to look into the costs of the continued use of 20 substances of very high concern (SVHCs), finding that although risks remain high, authorisation has considerably reduced harm to the environment and individuals. The authorisation requirements for SVHCs have led to many companies substituting them with safer alternatives.

10 December 2015, Paris - In order to accelerate widespread clean energy innovation, 20 national governments have announced a partnership…

Read Story

17 April, Brussels - A Greenovate! Europe study for the CENTRAL EUROPE Programme has concluded that transnational energy projects substantially…

Read Story

November 2014, Rome - The ancient city of Rome has welcomed an important new initiative for the large-scale integration of…

Read Story
Arrow-up